Sibutramine Use Associated with Reversible Hepatotoxicity

  1. Athina Chounta, MD;
  2. Sotirios Tsiodras, MD;
  3. Spyros Zouridakis, MD;
  4. Michalis Doumas, MD; and
  5. Helen Giamarellou, MD
  1. From Attikon University Hospital, Xaipari, Greece 12462.

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    TO THE EDITOR:

    Background: Obesity continues to be a major health problem in western nations (1) and in developing countries (2). Several prescription …

    This 100-word excerpt has been provided in the absence of an abstract.

    « Previous | Next Article »Table of Contents